0000905148-24-000183.txt : 20240116 0000905148-24-000183.hdr.sgml : 20240116 20240116164515 ACCESSION NUMBER: 0000905148-24-000183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240111 FILED AS OF DATE: 20240116 DATE AS OF CHANGE: 20240116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cuillerot Jean-Marie CENTRAL INDEX KEY: 0001696108 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41551 FILM NUMBER: 24535703 BUSINESS ADDRESS: BUSINESS PHONE: 781-674-4400 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc. CENTRAL INDEX KEY: 0001781174 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825125532 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-207-8979 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 form4.xml X0508 4 2024-01-11 0001781174 Acrivon Therapeutics, Inc. ACRV 0001696108 Cuillerot Jean-Marie C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true Chief Medical Officer false Stock Option (Right to Buy) 4.82 2024-01-11 4 A 0 99300 0 A 2034-01-10 Common Stock 99300 99300 D Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2025, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2024-01-16